Navigation Links
Prime Therapeutics Hires Steven Blumenfield as Chief Marketing Officer
Date:12/17/2008

ST. PAUL, Minn., Dec. 17 /PRNewswire/ -- Prime Therapeutics (Prime), a nationwide pharmacy benefit management (PBM) company, announced today that Steven Blumenfield has joined the organization as Chief Marketing Officer (CMO).

(Photo: http://www.newscom.com/cgi-bin/prnh/20081217/AQW507)

As CMO, Mr. Blumenfield has overall responsibility for Prime's marketing strategy, product development and other market-related initiatives. He will focus on continuing Prime's expansion and in helping to enhance the value that Prime delivers to its Blue Cross and Blue Shield clients and employer groups.

"In an effort to better position ourselves as an industry leading PBM, Prime has hired Steve Blumenfield as Chief Marketing Officer," said Tim Dickman, President and CEO of Prime Therapeutics. "Steve will be a great asset for enhancing strategic partnerships with our clients. With a health care and marketing background that spans 20 years, Steve understands health care, the pharmacy space, and Prime's clients and members. He will help us to partner in ways that will enhance our go-to-market capabilities."

Mr. Blumenfield was most recently a Health and Welfare Practice Leader and Principal at Towers Perrin. Prior to that role, he was responsible for pharmacy intellectual capital and the firm's pharmaceuticals sector. He received his bachelor's degree in Marketing from Rutgers University and his MBA from the University of Chicago's Graduate School of Business in Behavioral Decision Making and Business Policy.

Prime Therapeutics is a pharmacy benefit management company dedicated to providing, innovative, clinically-based, cost-effective pharmacy solutions for clients and members. Providing pharmacy benefit services nationwide to approximately 14.6 million covered lives, its client base includes
'/>"/>

SOURCE Prime Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Prime Therapeutics Receives TIPPS Certification
2. Lab Series(R) Skincare For Men Spa Indulges the 2007 Primetime Emmy(R) Nominees at the Sofitel(R) Los Angeles
3. Prime Access Creates Groundbreaking Ads Targeting Urban Teens for the White Houses National Youth Anti-Drug Media Campaign
4. Prime Therapeutics Announces URAC Accreditation
5. Prime Minister views innovative health technology at Imperial College London
6. GenPrime Initiates External Clinical Trials of its Bacterial Contamination Test for Rapid Detection of Bacteria in Platelets
7. Prime Healthcare Services Acquires Centinela Hospital Medical Center
8. Activist Groups Plea to Indian Prime Minister: Rollout Second-Line AIDS Treatment!
9. Announcing Prime Vendor Contract with LIHPA
10. Safety Concerns Prompt Prime to Remove Avandia(R) from Formulary
11. Fetal Alcohol Exposure May Prime Offspring for Alcoholism

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)... , SOUTHFIELD, Mich., Dec. 1 /PRNewswire-First...SE: FMR ) ("First Mercury" or the "Company") ann...f Directors declared a quarterly cash dividend of ...shareholders of record at the close of business on...inancial Corporation ,, First Mercury Financia...
(Date:12/1/2009)... identify those who would benefit from liver surge...Y, Dec. 1 (HealthDay News) -- A CT scan of liver t...y help predict overall survival after chemotherapy...stin) to cytotoxic chemotherapy has been shown to ...ectal cancer and to produce better results in pati...
(Date:12/1/2009)...LADELPHIA (December 1, 2009) Wistar Institute re... Pennsylvania and New York University have identif...ate early-stage lung tumors in people at high risk...ed online December 1 in Cancer Research , a journ..., could lead to a simple blood test to detect lung...
(Date:12/1/2009)... Ever thought you could quit s...vin Arthur Smith,s groundbreaking new system for q...ermanent. In just twenty eight days your cravings ... (PRWEB) December 1, 2009 -...g her eight-year addiction to nicotine, smoking at...
(Date:12/1/2009)... , LEHIGH VALLEY, Pa., Dec. 1 /PRNewswire-Firs...t has completed the previously announced sale of t...s, marketed under the Airthane® and Versathan... subsidiary of global polyurethane chemicals produ...Products, manufacturing facility in Paulsboro, N.J...
Breaking Medicine News(10 mins):Health News:CT Scan May Predict Colon Cancer Survival 2Health News:Wistar-led research team discovers genetic pattern that indicates early-stage lung cancer 2Health News:Wistar-led research team discovers genetic pattern that indicates early-stage lung cancer 3Health News:Former Cigarette Dealer Sells Business in Order to Fund Quit Smoking Book 2Health News:Former Cigarette Dealer Sells Business in Order to Fund Quit Smoking Book 3Health News:Air Products Completes Sale of Polyurethane Pre-Polymers Business to COIM USA 2
...,Corporation (Nasdaq: SMTS ) announced today that... to repurchase up to $15 million of its common,sha...e open market or in,privately negotiated transacti...186 common shares outstanding as of April,2, 2008....
... for lung invasion, study shows , , THURSD...nd to spread to specific tissues, and now research...pens. , Working with breast tumors, Joan Massague,...ling "relay" that enables the cancer to molecularl...
...b &,Ellis Company (NYSE: GBE ), a leading real es...report released today that aging baby boomers and,...fuel demand for,healthcare properties over the nex...llis, Chief Economist and author of the,report., ...
...roviders, and Patients, WASHINGTON, April 3, 2008...rganizations (AAPPO), in collaboration,with DMAA: ... a diabetes,toolkit for PPO executives to help hea...: http://www.newscom.com/cgi-bin/prnh/20060126/CL...
...n A. Clements is the recipient of the 2008 Pollin ...to our understanding of how lungs hold air, and to...piratory distress syndrome (RDS) in infants. Once ...t international award for pediatric research, reco...
...a Hall Institute, Professor Suzanne Cory, is one o...omson Scientific Citation Awards announced at the ...tific, a US-based international information analys...per their published research has had over a period...
Other Medicine News:Health News:Somanetics Announces Share Repurchase Program 2Health News:Molecular Cause of Breast Cancer Metastasis Discovered 2Health News:Molecular Cause of Breast Cancer Metastasis Discovered 3Health News:Aging Baby Boomers Will Drive Demand for Healthcare Properties Over Next Decade, Grubb & Ellis Report Reveals 2Health News:Aging Baby Boomers Will Drive Demand for Healthcare Properties Over Next Decade, Grubb & Ellis Report Reveals 3Health News:Aging Baby Boomers Will Drive Demand for Healthcare Properties Over Next Decade, Grubb & Ellis Report Reveals 4Health News:Aging Baby Boomers Will Drive Demand for Healthcare Properties Over Next Decade, Grubb & Ellis Report Reveals 5Health News:AAPPO Releases Diabetes Toolkit to Spur Action on Better Diabetes Care 2Health News:AAPPO Releases Diabetes Toolkit to Spur Action on Better Diabetes Care 3Health News:Pollin Pediatric Research Prize awarded for discovery of lifesaving treatment of RDS 2Health News:Pollin Pediatric Research Prize awarded for discovery of lifesaving treatment of RDS 3Health News:Pollin Pediatric Research Prize awarded for discovery of lifesaving treatment of RDS 4Health News:Professor Suzanne Cory honored with national citation award 2
(Date:12/1/2009)...BUQUERQUE, N.M., Dec. 1 Exagen Dia... that discovers, develops and markets proprietary ...Scott Glenn as chairman of the company,s board of ... to joining Exagen, Glenn was managing partner of ... of successful biomedical companies including Prom...
(Date:12/1/2009)..., BEIJING, Dec. 1 /PRNewswire-Asia/ -- Sino...r of biopharmaceutical products in China, announce...rder for its H1N1 vaccine, PANFLU.1(TM),from Chin...y for the national,purchase plan. Under this purch...ional one million doses of PANFLU.1 (TM) (15ug/0.5...
(Date:12/1/2009)..., REDWOOD CITY, Calif., Dec. 1 Cod...ationship and the signing of its second agreement ..., the world,s largest generic drug manufacturer. ...eutical products. Codexis announced an earlier ag...w agreement, Teva will use Codexis biocatalysis te...
Breaking Medicine Technology:Scott Glenn Joins Exagen Diagnostics as Chairman and CEO 2Sinovac Obtains Fourth H1N1 Vaccine Order from Chinese Central Government 2Sinovac Obtains Fourth H1N1 Vaccine Order from Chinese Central Government 3Codexis Expands Collaboration with Teva 2Newly found DNA catalysts cleave DNA with water molecule 9589 1Newly found DNA catalysts cleave DNA with water molecule 9589 2Researchers develop new more sensitive assay for detecting DNA methylation in colon cancer 9586 1Researchers develop new more sensitive assay for detecting DNA methylation in colon cancer 9586 2Researchers develop new more sensitive assay for detecting DNA methylation in colon cancer 9586 3Web Is Becoming One Stop Shopping for Health Help 54591 1Web Is Becoming One Stop Shopping for Health Help 54591 2Web Is Becoming One Stop Shopping for Health Help 54591 3
...s of Arimidex (anastrozole) over tamoxifen at prev...crease over time - even four years after ...ec. 14 New data from ATAC*, one of the,world,s la...l women with,early breast cancer, reinforce that a...ee, for longer. For the first time, anastrozole ha...
...ON, Mass., Dec. 18 Alseres,Pharmaceuticals, Inc.,...olled,the first subject in the initial stage of th... (POET-2) Phase III clinical trial program. This,s...Birmingham trial site,under the direction of Princ...nd Chairman of the Department of Neurology., ALTR...
Other Medicine Technology:Video: New Results From One of the World's Largest Breast Cancer Trials Herald Hope for Thousands of Women 2Video: New Results From One of the World's Largest Breast Cancer Trials Herald Hope for Thousands of Women 3Video: New Results From One of the World's Largest Breast Cancer Trials Herald Hope for Thousands of Women 4Video: New Results From One of the World's Largest Breast Cancer Trials Herald Hope for Thousands of Women 5Alseres Pharmaceuticals Initiates the ALTROPANE(R) POET-2 Phase III Clinical Trial Program 2Alseres Pharmaceuticals Initiates the ALTROPANE(R) POET-2 Phase III Clinical Trial Program 3Alseres Pharmaceuticals Initiates the ALTROPANE(R) POET-2 Phase III Clinical Trial Program 4Alseres Pharmaceuticals Initiates the ALTROPANE(R) POET-2 Phase III Clinical Trial Program 5
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
Medicine Products: